XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders' Equity Attributable to Acushnet Holdings Corp.
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss, Net of Tax
Retained Earnings
Treasury Stock
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2020     75,666          
Beginning balance at Dec. 31, 2020 $ 1,017,253 $ 983,949 $ 76 $ 925,385 $ (96,182) $ 199,776 $ (45,106) $ 33,304
Changes in stockholders' equity                
Net income 86,820 84,958       84,958   1,862
Other comprehensive loss (1,978) (1,978)     (1,978)      
Share-based compensation 5,369 5,369   5,369        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     181          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (3,945) (3,945)   (3,945)        
Purchases of common stock (Note 10) (2,377) (2,377)         (2,377)  
Share repurchase liability (Note 10) (2,347) (2,347)         (2,347)  
Dividends and dividend equivalents declared (12,767) (12,767)       (12,767)    
Dividends declared to noncontrolling interests (48)             (48)
Ending balance (in shares) at Mar. 31, 2021     75,847          
Ending balance at Mar. 31, 2021 1,085,980 1,050,862 $ 76 926,809 (98,160) 271,967 (49,830) 35,118
Beginning balance (in shares) at Dec. 31, 2020     75,666          
Beginning balance at Dec. 31, 2020 1,017,253 983,949 $ 76 925,385 (96,182) 199,776 (45,106) 33,304
Changes in stockholders' equity                
Dividends and dividend equivalents declared (50,846)              
Ending balance (in shares) at Dec. 31, 2021     75,855          
Ending balance at Dec. 31, 2021 1,080,267 1,042,844 $ 76 948,423 (99,582) 324,966 (131,039) 37,423
Changes in stockholders' equity                
Net income 82,026 81,045       81,045   981
Other comprehensive loss (4,945) (4,945)     (4,945)      
Share-based compensation 5,189 5,189   5,189        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     434          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (10,373) (10,373)   (10,373)        
Purchases of common stock (Note 10) (29,894) (29,894)         (29,894)  
Share repurchase liability (Note 10) 0              
Dividends and dividend equivalents declared (13,473) (13,473)       (13,473)    
Dividends declared to noncontrolling interests (101)             (101)
Ending balance (in shares) at Mar. 31, 2022     76,289          
Ending balance at Mar. 31, 2022 $ 1,108,696 $ 1,070,393 $ 76 $ 943,239 $ (104,527) $ 392,538 $ (160,933) $ 38,303